Cases 51 - 60 of 557
SHANNON v. MYLAN LABORATORIES, LTD. et al
as 1:2022cv03870
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
VINCENT SHANNON
Defendant:
MYLAN LABORATORIES, LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MYLAN INC. et al v. SOMAXON PHARMACEUTICALS, INC. et al
as 2:2022cv03944
Petitioner:
MYLAN INC. and MYLAN PHARMACEUTICALS INC.,
Plaintiff:
SOMAXON PHARMACEUTICALS, INC. and PROCOM ONE INC.
Respondent:
Currax Pharmaceuticals LLC, Currax Holdings LLC and Currax Holdings USA LLC
Interested Party:
PAR PHARMACEUTICAL INC, ACTAVIS ELIZABETH LLC, ACTAVIS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
BISHOP v. MYLAN LABORATORIES LTD. et al
as 1:2022cv03441
Plaintiff:
RENAE L. BISHOP
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THOMPSON v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv03438
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
BRIAN K. THOMPSON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WELCH v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv03400
Plaintiff:
MELODY WELCH
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CLARK v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv03392
Plaintiff:
MONA CLARK
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
RUPP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02780
Plaintiff:
BERNARD RUPP
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
LEWIS v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02524
Plaintiff:
ROBERT E. LEWIS
Defendant:
AUROBINDO PHARM, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THE ESTATE OF CONNIE KEEP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02461
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:
AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AMOIA v. MYLAN LABORATORIES LTD. et al
as 1:2022cv02438
Plaintiff:
THOMAS AMOIA
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
